384 related articles for article (PubMed ID: 21149768)
1. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
Brugts JJ; Deckers JW
Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
[No Abstract] [Full Text] [Related]
2. Are statins effective in high-risk primary prevention?
Dentali F; Guasti L
Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
[No Abstract] [Full Text] [Related]
3. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
4. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
5. Primary prevention for cardiovascular diseases: can statins replace aspirin?
Abdul Hadi M; Ming LC; Awaisu A
Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
[No Abstract] [Full Text] [Related]
6. Update on statins and other lipid-lowering drugs.
Miller CA
Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
[No Abstract] [Full Text] [Related]
7. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
Lardizabal JA; Deedwania P
Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention cardiovascular disease: better than drugs.
Pippin JJ
Arch Intern Med; 2010 Nov; 170(20):1860-1; author reply 1861. PubMed ID: 21059984
[No Abstract] [Full Text] [Related]
9. [Does statin therapy reduce the risk of stroke? A meta-analysis].
Sirol M; Bouzamondo A; Sanchez P; Lechat P
Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
[TBL] [Abstract][Full Text] [Related]
10. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
Gotto AM
Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
[No Abstract] [Full Text] [Related]
11. Benefit/risk ratio of statins in primary prevention.
Reidenberg MM
Clin Pharmacol Ther; 2008 Mar; 83(3):498-500. PubMed ID: 17538549
[No Abstract] [Full Text] [Related]
12. [Primary prevention of cardiovascular diseases with statins in women].
Alici G; Karpuz V; Karpuz H
Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
[TBL] [Abstract][Full Text] [Related]
13. [Statins in primary prevention of cardiovascular disease].
Adham S; Miranda S; Doucet J; Lévesque H; Benhamou Y
Rev Med Interne; 2018 Jan; 39(1):42-49. PubMed ID: 28866432
[TBL] [Abstract][Full Text] [Related]
14. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
[No Abstract] [Full Text] [Related]
15. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
[TBL] [Abstract][Full Text] [Related]
16. The role of statins in primary prevention.
Savill P
Practitioner; 2009; 253(1720):7. PubMed ID: 19715050
[No Abstract] [Full Text] [Related]
17. Cochrane review questions evidence for statins for primary prevention in low risk groups.
Mayor S
BMJ; 2011 Jan; 342():d480. PubMed ID: 21262902
[No Abstract] [Full Text] [Related]
18. Statins in women for primary prevention--is there evidence to back up their use??
Fenton A; Panay N
Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236
[No Abstract] [Full Text] [Related]
19. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
20. JUPITER study highlights C-reactive protein as a cardiac risk factor.
Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
